Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 215, Issue 12, Pages 3151-3164Publisher
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20180668
Keywords
-
Categories
Funding
- Canadian Institutes of Health Research [FDN-143338]
- Fonds de Recherche du Quebec - Sante Chercheur boursier clinicien Junior 2 salary award
- La Fondation du Grand Defi Pierre Lavoie
- Research Institute-McGill University Health Centre (Merck, Sharpe Dohme award)
- CSL Behring Canada
Ask authors/readers for more resources
Primary immunodeficiencies represent naturally occurring experimental models to decipher human immunobiology. We report a patient with combined immunodeficiency, marked by recurrent respiratory tract and DNA-based viral infections, hypogammaglobulinemia, and panlymphopenia. He also developed moderate neutropenia but without prototypical pyogenic infections. Using whole-exome sequencing, we identified a homozygous mutation in the inducible T cell costimulator ligand gene (ICOSLG; c.657C>G; p.N219K). Whereas WT ICOSL is expressed at the cell surface, the ICOSLN219K mutation abrogates surface localization: mutant protein is retained in the endoplasmic reticulum/Golgi apparatus, which is predicted to result from deleterious conformational and biochemical changes. ICOSLN219K diminished B cell costimulation of T cells, providing a compelling basis for the observed defect in antibody and memory B cell generation. Interestingly, ICOSLN219K also impaired migration of lymphocytes and neutrophils across endothelial cells, which normally express ICOSL. These defects likely contributed to the altered adaptive immunity and neutropenia observed in the patient, respectively. Our study identifies human ICOSLG deficiency as a novel cause of a combined immunodeficiency.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available